Diyabetik Hastalarda Hipoglisemi
Synopsis
Hypoglycemia is a major complication of intensive insulin therapy and a common endocrine emergency in emergency departments. Although diagnosis is generally based on Whipple's triad—encompassing blood plasma glucose <50 mg/dL, presence of hypoglycemic symptoms, and symptom resolution with treatment—the American Diabetes Association and the Endocrine Society recommend a diagnostic threshold of <70 mg/dL. Clinical findings are evaluated in two categories: adrenergic (hunger, cold sweating, tremor, palpitations) and neuroglycopenic (headache, confusion, seizures, loss of consciousness) symptoms. The International Hypoglycemia Study Group classifies hypoglycemia into three levels: high risk (<70 mg/dL), clinically significant (<54 mg/dL), and severe hypoglycemia requiring external assistance. The primary predisposing cause of hypoglycemia is insulin excess; however, age, renal or hepatic impairment, use of sulfonylureas and oral antidiabetics, and inadequate nutrition are other key risk factors. In treatment management, conscious patients are given 15–20 grams of rapidly metabolized oral carbohydrates. For unconscious patients, 50 mL of 50% dextrose IV (equivalent to 25 grams of glucose) is administered, and octreotide, diazoxide, or hydrocortisone may be added in refractory cases. Hospital admission may be required for patients using sulfonylureas or long-acting insulins. In COVID-19 patients, close glucose monitoring is vital because hydroxychloroquine and certain antivirals can increase the risk of hypoglycemia. Since recurrent hypoglycemic episodes increase mortality and morbidity risks, early diagnosis, effective treatment, and patient education are of critical importance.
References
Karcıoğlu, Ö., Ünverir, P. (2004). Hipoglisemi ve Acil Servis Yönetimi. Akademik Acil Tıp Dergisi içinde (40-46). İzmir: Akademisyen Kitapevi
TEMD (2020). Diabetes mellitus ve komplikasyonlarının tanı, tedavi ve izlem klavuzu 2020. (01.12.2020 tarihinde http://temd.org.tr/admin/uploads/tbl_kilavuz/20200625154506-2020tbl_kilavuz86bf012d90.pdf adresinden ulaşılmıştır).
Tintinalli, E. (2013). Tintinalli Acil Tıp, Kapsamlı Bir Çalışma Kılavuzu. (Çete, Y., Denizbaşı, A., Çevik, A.A., Oktay, C., Atilla, A., Çev. Ed.). İstanbul: Nobel Tıp Kitabevi
Yavuz D., Hipoglisemi Güncelleme, Endokrin Vakalar (2012), 46-49. ISBN: 978-605-4499-26-7